POLYMED

Poly Medicure Share PricePoly Medicure

₹941.85
-29.95 (-3.08%)
  • Advice
  • Hold
As on 30 March, 2023 | 14:06 BSE: 531768 NSE: POLYMED

Poly Medicure Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Poly Medicure

Start SIP

Poly Medicure Share Price

  • Over 1 Month 0.53%
  • Over 3 Month 5.01%
  • Over 6 Month 6.82%
  • Over 1 Year 6.05%

Poly Medicure Key Statistics

P/E Ratio 57.7
PEG Ratio 11.6
Market Cap Cr 9,039
Price to Book Ratio 8.3
EPS 14.6
Dividend 0.3
Relative Strength Index 48.33
Money Flow Index 62.39
MACD Signal 11.2
Average True Range 46.06

Poly Medicure Investment Rating

  • Master Rating:
  • Poly Medicure has an operating revenue of Rs. 1,065.89 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 21% is great, ROE of 13% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 7% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It has recently broken out of a base in its weekly chart and is trading around -7% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 73 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 37 indicates it belongs to a strong industry group of Medical-Systems/Equip and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Poly Medicure Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 272264239244
Operating Expenses Qtr Cr 203198191188
Operating Profit Qtr Cr 68664857
Depreciation Qtr Cr 14141414
Interest Qtr Cr 5011
Tax Qtr Cr 1716913
Net Profit Qtr Cr 48452938

Poly Medicure Technicals

EMA & SMA

Current Price
₹941.85
-29.95 (-3.08%)
  • Bullish Moving Average
  • ___
  • 7
  • Bearish Moving Average
  • ___
  • 9
  • 20 Day
  • 955.21
  • 50 Day
  • 937.42
  • 100 Day
  • 920.28
  • 200 Day
  • 896.1
  • 20 Day
  • 965.49
  • 50 Day
  • 921.28
  • 100 Day
  • 927.32
  • 200 Day
  • 872.85

Poly Medicure Resistance and Support

PIVOT
₹969.32
Resistance
First Resistance 991.59
Second Resistance 1011.37
Third Resistance 1033.64
RSI 48.33
MFI 62.39
MACD Single Line 11.2
MACD 7.41
Support
First Resistance 949.54
Second Resistance 927.27
Third Resistance 907.49

Poly Medicure Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 81,603 3,832,077 46.96
Week 58,477 2,451,347 41.92
1 Month 123,205 3,409,080 27.67
6 Month 57,360 1,955,415 34.09

Poly Medicure Result Highlights

Poly Medicure Synopsis

NSE-Medical-Systems/Equip

Poly Medicure Lt is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 879.36 Cr. and Equity Capital is Rs. 47.95 Cr. for the Year ended 31/03/2022. Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923.
Market Cap 9,039
Sales 1,019
Shares in Float 4.51
No of funds 95
Yield 0.27
Book Value 8.39
U/D Vol ratio 2
LTDebt / Equity 3
Alpha 0.04
Beta 0.53

Poly Medicure

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 53.33%53.33%53.34%
Mutual Funds 3.01%3.03%2.92%
Insurance Companies 0.18%0.18%0.18%
Foreign Portfolio Investors 16.33%16.27%15.59%
Financial Institutions/ Banks
Individual Investors 11.18%11.2%11.93%
Others 15.97%15.99%16.04%

Poly Medicure Management

Name Designation
Mr. Devendra Raj Mehta Chairman
Mr. Himanshu Baid Managing Director
Mr. Rishi Baid Joint Managing Director
Mr. Jugal Kishore Baid Non Executive Director
Mrs. Mukulika Baid Non Executive Director
Mr. Alessandro Balboni Non Executive Director
Dr. Sandeep Bhargava Ind. Non-Executive Director
Mr. Amit Khosla Ind. Non-Executive Director
Ms. Sonal Mattoo Ind. Non-Executive Director
Mr. Prakash Chand Surana Ind. Non-Executive Director
Dr. Shailendra Raj Mehta Ind. Non-Executive Director
Dr. Ambrish Mithal Additional Director

Poly Medicure Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Poly Medicure MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 23945
UTI Unit Linked Insurance 5069
WhiteOak Capital Flexi Cap Fund Regular Growth 1028
UTI Healthcare Fund Regular Plan Growth 655
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 388

Poly Medicure FAQs

What is Share Price of Poly Medicure ?

Poly Medicure share price is ₹941 As on 30 March, 2023 | 13:52

What is the Market Cap of Poly Medicure ?

The Market Cap of Poly Medicure is ₹9039 Cr As on 30 March, 2023 | 13:52

What is the P/E ratio of Poly Medicure ?

The P/E ratio of Poly Medicure is 57.7 As on 30 March, 2023 | 13:52

What is the PB ratio of Poly Medicure ?

The PB ratio of Poly Medicure is 8.3 As on 30 March, 2023 | 13:52

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number